abrdn Life Sciences Investors (HQL) to Issue Quarterly Dividend of $0.56 on May 30th

abrdn Life Sciences Investors (NYSE:HQL) announced a quarterly dividend on Monday, May 11th. Investors of record on Thursday, May 21st will be paid a dividend of 0.56 per share on Saturday, May 30th. This represents a c) dividend on an annualized basis and a dividend yield of 12.4%. The ex-dividend date is Thursday, May 21st.

abrdn Life Sciences Investors Stock Up 0.1%

Shares of HQL opened at $18.14 on Wednesday. The stock has a 50 day moving average of $17.01 and a 200 day moving average of $16.99. abrdn Life Sciences Investors has a 12 month low of $11.92 and a 12 month high of $18.46.

abrdn Life Sciences Investors Company Profile

abrdn Life Sciences Investors (NYSE: HQL) is a closed-end management investment company that seeks capital appreciation through investment in the life sciences sector. Established in 1994, the trust focuses on equity and equity-related securities of companies engaged in biotechnology, pharmaceuticals, medical devices, diagnostics and related fields. Its closed-end structure allows portfolio managers to maintain a stable pool of capital, pursue long-term investment strategies and employ leverage when deemed appropriate.

The fund’s portfolio spans both public and private companies, with an emphasis on businesses driving innovation in drug development, gene therapy, precision medicine and healthcare technology.